Tim Nguyen, MD

Articles

Genomic Predictors Associated With Exceptional Response to Systemic Therapy in Advanced Pancreatic Cancer

Suneel D. Kamath, MD;Joanna Roopkumar, MD;Ying Ni, PhD;Minqian Shen, MD, PhD;Pablo Bejarano, MD;Daniela Allende, MD;Arun Nagarajan, MD;Tim Nguyen, MD;Bachar Dergham, MD;Dale Shepard, MD, PhD;Marc A. Shapiro, MD;Michael J. McNamara, MD;Bassam N. Estfan, MD;Kanika G. Nair, MD;Alok A. Khorana, MD

December 15th 2023

Suneel K. Kamath, MD, et al investigated exceptional responders and the correlation of nonsynonymous mutations for patients with advanced pancreatic cancer.

Latest Updated Articles

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.

Published: August 9th 2024 | Updated: August 14th 2024

Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets

Published: June 2nd 2024 | Updated: June 3rd 2024

OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer

Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.

Published: May 6th 2024 | Updated: May 21st 2024

FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications

Published: May 27th 2011 | Updated: November 21st 2024

A 71-Year-Old Male Presents for Evaluation of Painless Bump on His Chin

Published: August 26th 2011 | Updated: November 21st 2024

Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes

Published: April 21st 2021 | Updated: November 21st 2024

How to Radiologically Assess and Follow Response After Treatment of Hepatocellular Carcinoma

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777